Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source?
about
Endometrial mesenchymal stem cells as a cell based therapy for pelvic organ prolapseStem Cell Therapy for Treatment of Stress Urinary Incontinence: The Current Status and ChallengesAcute in vivo response to an alternative implant for urogynecology.Prevention and management of pelvic organ prolapse.Development of an implantable synthetic membrane for the treatment of preterm premature rupture of fetal membranes.Developing Repair Materials for Stress Urinary Incontinence to Withstand Dynamic Distension.Production of ascorbic acid releasing biomaterials for pelvic floor repair.In vitro differentiation of endometrial regenerative cells into smooth muscle cells: Α potential approach for the management of pelvic organ prolapseIn vivo effects of human adipose-derived stem cells reseeding on acellular bovine pericardium in nude mice.The scientific basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP).Application of Tissue Engineering to Pelvic Organ Prolapse and Stress Urinary Incontinence.Tissue-engineering with muscle fiber fragments improves the strength of a weak abdominal wall in rats.Electrospun biodegradable microfibers induce new collagen formation in a rat abdominal wall defect model: A possible treatment for pelvic floor repair?Tunable tissue scaffolds fabricated by in situ crosslink in phase separation system.Biodegradable scaffolds designed to mimic fascia-like properties for the treatment of pelvic organ prolapse and stress urinary incontinence.Nanotechnology in the Treatment of IncontinenceEffect of Optimized Concentrations of Basic Fibroblast Growth Factor and Epidermal Growth Factor on Proliferation of Fibroblasts and Expression of Collagen: Related to Pelvic Floor Tissue Regeneration
P2860
Q26744319-926C218C-349E-47B1-8BB7-09D48E0E1585Q26765866-8CA08BFA-FC8C-4274-A803-5AAF253DA87FQ34014270-1B493A66-836A-4E8D-B1B4-A07E3F82B9F6Q34201944-68E80D3B-03AF-4552-B6E6-BBBD4E55081CQ35816950-F7786798-58F1-4D73-A5B5-7E20B9EF1173Q35959161-920B19FE-E692-47A1-811B-31E70A744BDBQ36371230-805137D4-F220-4378-9861-F75DC3744C81Q36983831-0C7856C9-151D-41AA-A063-92869ACA24A3Q37071642-5A6C4DB8-8929-44E1-AF0D-98C2CCA067B0Q38216968-F125D856-2F3B-4DFF-957F-D7BD55FA4077Q38668439-70923BF0-C5EA-4B6C-848C-43420B1111E9Q38830787-C0FA3355-6A05-4270-A67D-17DC8DC64F35Q38901300-FBEE6BDE-E4E7-4D73-8C1E-A5820FA98169Q39011132-90D40E92-AD29-46B5-A636-D4EE2042B23BQ39983055-4785AC05-C04E-4507-A3F9-545E66EEB1C0Q57452435-346E3CAF-6BE3-4931-9E01-166AB4C355DDQ58763950-67530A25-8EEB-497E-B4AB-739CA7EF10C7
P2860
Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Developing a tissue engineered ...... an prolapse-which cell source?
@en
Developing a tissue engineered ...... an prolapse-which cell source?
@nl
type
label
Developing a tissue engineered ...... an prolapse-which cell source?
@en
Developing a tissue engineered ...... an prolapse-which cell source?
@nl
prefLabel
Developing a tissue engineered ...... an prolapse-which cell source?
@en
Developing a tissue engineered ...... an prolapse-which cell source?
@nl
P2093
P2860
P356
P1476
Developing a tissue engineered ...... an prolapse-which cell source?
@en
P2093
Altaf Mangera
Nadir I Osman
Sabiniano Roman
Sheila MacNeil
P2860
P304
P356
10.1002/NAU.22443
P577
2013-07-19T00:00:00Z